INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined garlic. Clear

People assigned to a diet, food or program and measured.

5 studies

2021 / Randomized placebo-controlled triple-blind clinical trial

Garlic tablet supplementation significantly reduced endometriosis-related pain compared to placebo over three months.

In a triple-blind trial, 60 women with endometriosis were randomly assigned to receive usual care plus either 400 mg garlic tablets or identical placebo tablets for three months. Pain was measured before intervention and at one-, two-, and three-month follow-ups using a four-part VAS. The overall severity of pain decreased from 6.51 ± 0.86 to 1.83 ± 1.25 in the garlic group (p < 0.05), but increased from 6.41 ± 1.12 to 6.65 ± 1.37 in the control group (p = 0.02). Repeated measures ANOVA demonstrated a significant difference in pain score changes between the groups (p < 0.001, np2 = 0.572).

Amirsalari S, Behboodi Moghadam Z, Taghizadeh Z, et al. Evid Based Complement Alternat Med, 2021. PMID 34335819

2016 / Randomized, double-blind, placebo-controlled trial

Garlic powder supplementation significantly reduced body weight and body fat mass in patients with nonalcoholic fatty liver disease.

In this trial, 110 subjects with NAFLD were randomly assigned to receive either two garlic tablets daily (containing 400 mg of garlic powder) or placebo tablets. The intervention group demonstrated significant reductions in body weight and body fat mass (P < 0.05). Percentage change in body weight was significantly greater in the intervention group compared to the control group (-2.6 vs. -0.7, P = 0.02). Neither group showed significant changes in total body water or lean body mass (P > 0.05), and no serious side effects were reported.

Soleimani D, Paknahad Z, Askari G, et al. Adv Biomed Res, 2016. PMID 26955623

2014 / Intervention study

Foods such as raw apple, spinach, and parsley deodorized garlic breath volatiles through probable enzymatic and polyphenolic mechanisms.

Researchers evaluated the ability of various foods and beverages consumed immediately after raw garlic ingestion to reduce garlic breath volatiles using selected ion flow tube-mass spectrometry. Probable enzymatic deodorization was observed with raw apple, parsley, spinach, and mint, whereas polyphenolic deodorization occurred with microwaved apple, green tea, and lemon juice. Chlorophyllin and whey protein did not demonstrate effective deodorization. Headspace concentrations did not correlate well to breath treatments.

Munch R, Barringer SA J Food Sci, 2014. PMID 24592995

2005 / Randomized, double-blinded, placebo-controlled crossover study

Ingestion of garlic did not show evidence of significant systemic mosquito repellence in a preliminary trial.

In a randomized, double-blinded, placebo-controlled crossover trial, subjects consumed either garlic during one visit or a placebo during another visit before exposure to laboratory-reared Aedes aegypti mosquitoes. Researchers measured the number of mosquitoes that did not feed, the number of bites, mosquito weights after feeding, and the amount of blood ingested. The data showed no evidence of significant systemic mosquito repellence. The authors noted a limitation that more prolonged garlic ingestion might be necessary to accomplish repellence.

Rajan TV, Hein M, Porte P, et al. Med Vet Entomol, 2005. PMID 15752181

2001 / Randomized controlled trial

An allicin-containing garlic supplement reduced common cold incidence and symptom duration.

In a 12-week trial, 146 volunteers took either an allicin-containing garlic pill or a placebo daily. Participants receiving garlic experienced significantly fewer colds than those on placebo (24 versus 65, P < .001). The garlic group also recorded fewer total days with viral illness (111 versus 366, P < .05) and shorter average symptom duration (1.52 versus 5.01 days, P < .001).

Josling P Adv Ther, 2001. PMID 11697022